Skip to main content

People in the News: Aug 2, 2011

Premium

David Okrongly has stepped down as CEO of Quanterix. Executive Chairman Martin Madaus is currently acting as the company's interim CEO. Madaus has been executive chairman since November 2010. Previously he was president and CEO of Millipore.


Proteome Sciences has tapped Glenn Barney to be vice president of business development in North America. Barney previously held the same title at NextGen Sciences, where he was responsible for commercializing biomarker discovery services. Before that, he held senior positions at Decision Biomarkers and PerkinElmer.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.